Ideggyogyaszati Szemle-Clinical Neuroscience, an esteemed publication under the auspices of LITERATURA MEDICA, serves as a pivotal platform in the field of neurology and clinical neuroscience. Established in Hungary, this journal has been committed to advancing the understanding of neurological disorders and treatments since its inception. With its ISSN 0019-1442 and E-ISSN 2498-6208, it provides a unique local perspective alongside valuable contributions to the global discourse in neuroscience. Despite earning a Q4 quartile ranking in both Neurology and Clinical Neurology, the journal remains dedicated to publishing high-quality research that contributes to the scientific community's collective knowledge. Its coverage spans significant converged years from 1954 to 1985 and now continues through 2024, reflecting a rich historical foundation. Recognizing the importance of open access, the journal strives to enhance accessibility, albeit currently lacking a formal open-access model. Researchers, professionals, and students in the field will find in Ideggyogyaszati Szemle a resource vital for keeping abreast of emerging trends and findings in neurological science.

Stroke Research and Treatment is a premier Open Access journal published by HINDAWI LTD, dedicated to advancing the understanding and management of stroke and related neurological disorders. Since its inception in 2010, this journal has established itself as a valuable resource for researchers and clinicians in the field of neurology, providing a platform for high-quality, peer-reviewed articles that aim to improve patient outcomes and stimulate clinical practice innovations. With a 2023 Scopus ranking placing it in the Q3 category and a percentile ranking of 44th in clinical neurology, the journal is positioned to influence the ongoing discourse in stroke research. Stroke Research and Treatment embraces a global audience, with its editorial operations based in London, England. The journal's commitment to open access ensures that its content is freely available to all, promoting extensive dissemination and engagement in this critical field of study. Researchers, professionals, and students are encouraged to contribute their findings to this dynamic journal, fostering collaboration and knowledge sharing in the ongoing fight against stroke.

JOURNAL OF CLINICAL NEUROPHYSIOLOGY, an esteemed publication under Lippincott Williams & Wilkins, has been at the forefront of disseminating cutting-edge research and clinical advancements since its inception in 1984. With an ISSN of 0736-0258 and an E-ISSN of 1537-1603, this journal serves as a vital resource for professionals and researchers in the fields of medicine, neurology, and physiology, consistently maintaining its prestigious Q2 ranking in various categories as of 2023. It holds a significant position in Scopus rankings, particularly in Clinical Neurology and Physiology, providing insights that are essential for clinicians, neurologists, and scholars alike. Although it does not currently offer open access, it remains a crucial platform for advancing knowledge and practice in clinical neurophysiology. The journal not only aims to foster a deeper understanding of neurophysiological methods and their clinical applications but also encourages innovative research that addresses current challenges in the field. By bridging theory and practice, the JOURNAL OF CLINICAL NEUROPHYSIOLOGY plays an indispensable role in enhancing the quality of patient care and advancing the science of neurology.

Welcome to the Erciyes Medical Journal, a distinguished publication from the Erciyes University School of Medicine that has been dedicated to advancing the field of medical science since its establishment. This Open Access journal, available in both print (ISSN: 2149-2247) and online (E-ISSN: 2149-2549), offers researchers unparalleled access to cutting-edge research and medical advancements. Following its transition to open access in 2018, the journal aims to democratize knowledge, allowing healthcare professionals, researchers, and students alike to engage with high-quality content that is both accessible and impactful. Although its coverage in databases such as Scopus has been discontinued since 2018, the Erciyes Medical Journal continues to foster scholarly dialogue and innovation in medicine, addressing critical health issues relevant to the global community. As a hub for knowledge exchange, this journal not only publishes original research articles but also encourages the submission of reviews, case studies, and clinical practice articles, thereby facilitating a comprehensive understanding of medical challenges and breakthroughs.

Basic and Clinical Neuroscience, published by Iran University of Medical Sciences, is a distinguished open-access journal that has been operational since 2009, providing a platform for the dissemination of significant research in the fields of neuroscience and neurology. With the ISSN 2008-126X and E-ISSN 2228-7442, this journal serves as a vital resource for researchers, clinicians, and students by facilitating access to the latest findings and advancements in cellular and molecular neuroscience as well as clinical neurology. Although currently rated in Q4 for Cellular and Molecular Neuroscience and Q3 for Clinical Neurology as of 2023, it aims to enhance its standing through the publication of high-quality, peer-reviewed research. The journal has achieved a Scopus rank placing it in the 38th percentile for Neurology and the 13th percentile for Neuroscience, indicating a growing recognition of its contributions. With its commitment to open access, Basic and Clinical Neuroscience not only contributes to the scientific community in Iran but also strives to connect researchers worldwide, fostering collaborative efforts in tackling complex neurological challenges.

Epileptic Disorders is a leading journal dedicated to the field of epilepsy research and its clinical implications, published by Wiley. With its ISSN 1294-9361 and E-ISSN 1950-6945, the journal has established a significant presence in the medical and neurological communities, reflecting its commitment to advancing knowledge in the study of epilepsy and related disorders. Covering a broad spectrum of topics, Epileptic Disorders aims to provide a platform for researchers and clinicians to share cutting-edge research findings, clinical insights, and innovative treatments, maintaining a robust presence in Q2 quartiles across multiple categories including Medicine (miscellaneous) and Neurology. The journal, which has been in continuous publication since 1999, also ranks within the 51st and 47th percentiles in the Scopus rankings for Medicine and Neuroscience, respectively, underscoring its relevance and impact in the field. Although not an open-access publication, Epileptic Disorders remains a crucial resource for those seeking to deepen their understanding of epilepsy and improve patient care through research.

South Asian Journal of Cancer, published by GEORG THIEME VERLAG KG, is a pivotal platform for research in the fields of oncology and cancer research. Established in 2012 and operating under an Open Access model, this journal aims to disseminate high-quality, peer-reviewed articles that address crucial developments in cancer treatment, prevention, and research, particularly within the South Asian context. Despite its young history, the journal has been positioned within the Q4 quartile for both Cancer Research and Oncology, and while current Scopus rankings indicate it resides in the lower percentiles, its commitment to amplifying regional voices and research is invaluable. With its headquarters in Stuttgart, Germany, and a global readership, South Asian Journal of Cancer is dedicated to enhancing collaboration among researchers, healthcare professionals, and students, fostering a space for innovative ideas and advancements in cancer care as we progress through to 2024.

EPILEPSY & BEHAVIOR is a premier journal dedicated to advancing the field of neurology and behavioral neuroscience, published by Academic Press Inc. Elsevier Science. With a focus on the complex interplay between epilepsy and behavioral disorders, this journal serves as a pivotal platform for researchers, clinicians, and educators alike. The journal holds a commendable position with a Q2 ranking in key categories such as Behavioral Neuroscience and Clinical Neurology, highlighting its influence and contributions to the scientific community. Notably, EPILEPSY & BEHAVIOR is indexed in Scopus, ranking in the top percentiles across various related fields, which underscores the quality and relevance of the research it publishes. As it navigates from its inception in 2000 to its ongoing work into 2024, the journal remains committed to disseminating high-quality research and insights that address critical issues in epilepsy and associated behavioral challenges, providing invaluable resources for ongoing education and innovation in the field.

Annals of Indian Academy of Neurology is a premier open access journal dedicated to advancing the field of Neurology, serving as a vital resource for researchers, healthcare professionals, and students since its inception in 2006. Published by the esteemed Wolters Kluwer Medknow Publications, this journal has established itself within the academic community, boasting a Q3 quartile ranking in clinical neurology according to the 2023 category quartiles and a Scopus rank placing it in the 35th percentile among 400 comparable journals. With a focus on clinical advancements and research innovations in neurology, the journal aims to disseminate high-quality and impactful studies that address the complex challenges faced in the neurological landscape, particularly within the Indian context. The open access model ensures that the latest research is readily accessible to a global audience, thereby promoting collaboration and knowledge sharing within the neurosciences.

Anemia is a distinguished open-access journal published by HINDAWI LTD, focusing on the intricate and vital field of hematology and related disciplines. Since its inception in 2010, this journal has been dedicated to advancing our understanding of blood disorders, with a particular emphasis on anemia, through the dissemination of high-quality research that is freely accessible to a global audience. The journal's evolving scope from its founding through 2024 embodies its commitment to include the latest breakthroughs and methodologies in cell biology and hematological research. With its presence in prestigious databases and a tiered ranking that places it in the Q3 category in Hematology and Q4 in Cell Biology as of 2023, Anemia serves as an invaluable resource for researchers, clinicians, and students alike. The journal is indexed with a respectable position in Scopus, ranking 52 out of 137 in Hematology, highlighting its growing influence in the medical and scientific communities. With continued emphasis on open access, Anemia not only fosters collaborative research but also ensures that crucial findings reach those who need them most, enhancing educational outcomes and clinical practices worldwide.